kt 6149 has been researched along with porfiromycin in 1 studies
| Studies (kt 6149) | Trials (kt 6149) | Recent Studies (post-2010) (kt 6149) | Studies (porfiromycin) | Trials (porfiromycin) | Recent Studies (post-2010) (porfiromycin) |
|---|---|---|---|---|---|
| 39 | 3 | 0 | 91 | 5 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bruijn, EA; Pattyn, G; Tjaden, UR; van Oosterom, AT | 1 |
1 other study(ies) available for kt 6149 and porfiromycin
| Article | Year |
|---|---|
Determination of the new anticancer agent KW 2149, 7-N-[2-[2-(gamma-L-glutamylamino)ethyl)dithio)ethyl]mitomycin C, an analogue of mitomycin C.
Topics: Antineoplastic Agents; Chromatography, High Pressure Liquid; Humans; Mitomycins; Molecular Structure; Porfiromycin | 1991 |